Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Sorrento Therpt (SRNE)
Sorrento Therpt (SRNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sorrento Therpt 4955 DIRECTORS PLACE SAN DIEGO CA 92121 USA

www.sorrentotherapeutics.com P: 858-203-4100

Description:

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 145,009
Enterprise Value, $K 160,729
Shares Outstanding, K 471,880
Annual Sales, $ 52,900 K
Annual Net Income, $ -428,330 K
Last Quarter Sales, $ 17,400 K
Last Quarter Net Income, $ -89,580 K
60-Month Beta 1.95
% of Insider Shareholders 2.60%
% of Institutional Shareholders 34.48%
Float, K 459,611
% Float 97.40%
Short Volume Ratio 0.55

Growth:

1-Year Return -88.95%
3-Year Return -85.84%
5-Year Return -95.73%
5-Year Revenue Growth 549.08%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 11/08/22
Latest Earnings Date 02/28/23
Earnings Per Share ttm -0.63
EPS Growth vs. Prev Qtr 35.48%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/01/13

SRNE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -282.82%
Return-on-Assets % -57.64%
Profit Margin % -809.70%
Debt/Equity 0.14
Price/Sales 1.91
Price/Cash Flow N/A
Price/Book 1.11
Book Value/Share 0.28
Interest Coverage -44.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar